NCT00420342 - Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

PostmenopauseHypertensionPre-Hypertension

Interventions

DRUG

Drospirenone/17ß-estradiol (Angeliq, BAY86-4891)

SH K 00641 A -Active study medication encapsulated tablet

DRUG

Drospirenone/17ß-estradiol (Angeliq, BAY86-4891)

SH K 00641 B - Active study medication encapsulated tablet

DRUG

SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM)

Active control encapsulated tablet

Trial Locations (9)

Philadelphia

Arlington

Columbia

Daytona Beach

Miami

Paw Paw

Las Vegas

San Diego

Greenbrae